FindTrial
Sign In

Evaluation of the efficacy of the real-world hormones for improving visual function in high myopia

Evaluation of the efficacy of the real-world hormones for improving visual function in high myopia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059326
Enrollment
Unknown
Registered
2022-04-28
Start date
2017-01-01
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

The treatment group:retrobulbar glucocorticoid therapy

Sponsors

The Scond Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.High myopia after cataract surgery; 2.Best corrected visual acuity between 0.02~1.0 or visual field MD < -3.0dB; 3.Corrected refractive state close to emmetropia; 4.No significant macular retinopathy.

Exclusion criteria

Exclusion criteria: 1.No history of other eye surgery; 2.Eye diseases other than high myopia.

Design outcomes

Primary

MeasureTime frame
best corrected vision acuity;visual field;—

Countries

China

Contacts

Public ContactXiaohua Zhu
zxh600705@163.com+86 137 0748 3919

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026